Clinical Trial: Guo&Amp;'s Distal Entry Tear Repair: A Multicenter, Randomized Controlled Study of the Novel WeFlow-EndoPatch System (Gallant Study)

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06945809) titled 'Guo&Amp;'s Distal Entry Tear Repair: A Multicenter, Randomized Controlled Study of the Novel WeFlow-EndoPatch System (Gallant Study)' on April 18.

Brief Summary: A Multicenter, Randomized Controlled Study About the Safety and Efficacy of WeFlow-EndoPatch Aortic Endovascular Patch System manufactured by EndoNom Medtech (Hangzhou) Co., Ltd. for Chronic Aortic Dissection . (GALLANT Study)

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Aortic Dissection Distal Tear in the Descending Aorta After Aortic Dissection Surgery

Intervention: DEVICE: WeFlow-EndoPatch Aortic Endovascular Patch System

The WeFlow-EndoPat...